Adaptive Biotechnologies Corporation
ADPT
$12.63
$0.3352.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.20% | 11.40% | -5.05% | 30.62% | 2.70% |
| Total Depreciation and Amortization | -4.84% | 6.36% | -3.11% | -8.24% | -4.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.44% | -6.72% | 1.92% | -36.26% | 48.04% |
| Change in Net Operating Assets | 67.14% | -628.76% | 123.44% | -560.97% | 127.42% |
| Cash from Operations | 56.36% | -128.04% | 53.85% | -56.42% | 54.88% |
| Capital Expenditure | 47.97% | -1,473.75% | 76.74% | 80.10% | -14.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.09% | 20.87% | 294.23% | -25.97% | -83.47% |
| Cash from Investing | -86.92% | 15.62% | 318.37% | -10.04% | -86.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -70.46% | 4,192.13% | 217.50% | 33.33% | -31.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.46% | 4,192.13% | 217.50% | 33.33% | -31.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -394.25% | -73.96% | 144.88% | -90.75% | -283.81% |